News
Nine presentations on Inflammatory Bowel Disease Prediction, Monitoring and Therapy Optimization SAN DIEGO, CA / ACCESS Newswire / May 4, 2025 / Prometheus Laboratories Inc. ("Prometheus"), ...
The authors of a review article on the future of ustekinumab biosimilars for treating Crohn disease (CD) discussed key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback